English | Español
Amanda Rupp | Mar 11, 2016

ALS Association invests in new proposals for ALS treatment developments
Jamie Barrand | Mar 11, 2016

Opdivo under consideration in Europe for new indications
Jeff Gantt | Mar 10, 2016

TiGenix’s Cx601 trial shows positive results
Vimbai Chikomo | Mar 10, 2016

HHS estimates 43,000 have lost Obamacare tax credit after failing to file 2014 returns
Kerry Goff | Mar 10, 2016

Aetna says Hep C coverage likely to expand with new research
Jamie Barrand | Mar 9, 2016

FDA approves Imbruvica as first-line therapy for chronic lymphocytic leukemia
Jamie Barrand | Mar 9, 2016

University of Cincinnati using genetic clues from Black Plague to develop HIV therapies
Jamie Barrand | Mar 9, 2016

Possible flu therapy fast-tracked by FDA

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’